{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:58:24Z","timestamp":1766138304151,"version":"3.37.3"},"reference-count":31,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"Research Foundation of Beijing Shijitan Hospital Affiliated to Capital Medical University","award":["(2022-C03)"],"award-info":[{"award-number":["(2022-C03)"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(82004011)"],"award-info":[{"award-number":["(82004011)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/14740338.2023.2216453","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:19:10Z","timestamp":1684477150000},"page":"785-792","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Sodium-glucose cotransporter-2 inhibitors and cardiovascular safety profile: a pharmacovigilance analysis of the US food and drug administration adverse event reporting system"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0428-4800","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6963-1052","authenticated-orcid":false,"given":"Chen","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6036-8942","authenticated-orcid":false,"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dechun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2326-5170","authenticated-orcid":false,"given":"Mingnan","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"doi-asserted-by":"publisher","key":"e_1_3_5_3_1","DOI":"10.1007\/s11886-019-1107-y"},{"doi-asserted-by":"publisher","key":"e_1_3_5_4_1","DOI":"10.1016\/j.phrs.2016.09.040"},{"doi-asserted-by":"publisher","key":"e_1_3_5_5_1","DOI":"10.1038\/s41569-020-0406-8"},{"doi-asserted-by":"publisher","key":"e_1_3_5_6_1","DOI":"10.1161\/CIRCRESAHA.117.311588"},{"doi-asserted-by":"publisher","key":"e_1_3_5_7_1","DOI":"10.1016\/j.jacc.2018.03.009"},{"doi-asserted-by":"publisher","key":"e_1_3_5_8_1","DOI":"10.1056\/NEJMoa072761"},{"doi-asserted-by":"publisher","key":"e_1_3_5_9_1","DOI":"10.1016\/j.jcjd.2019.09.004"},{"doi-asserted-by":"publisher","key":"e_1_3_5_10_1","DOI":"10.7759\/cureus.16868"},{"doi-asserted-by":"publisher","key":"e_1_3_5_11_1","DOI":"10.1161\/CIRCULATIONAHA.116.021887"},{"doi-asserted-by":"publisher","key":"e_1_3_5_12_1","DOI":"10.1186\/s12933-020-01197-z"},{"doi-asserted-by":"publisher","key":"e_1_3_5_13_1","DOI":"10.1016\/S2213-8587(19)30066-X"},{"doi-asserted-by":"publisher","key":"e_1_3_5_14_1","DOI":"10.1001\/jama.2018.3024"},{"doi-asserted-by":"publisher","key":"e_1_3_5_15_1","DOI":"10.1007\/s40290-020-00329-w"},{"doi-asserted-by":"publisher","key":"e_1_3_5_16_1","DOI":"10.7150\/ijms.6048"},{"doi-asserted-by":"publisher","key":"e_1_3_5_17_1","DOI":"10.1186\/s12911-020-1053-z"},{"doi-asserted-by":"publisher","key":"e_1_3_5_18_1","DOI":"10.1007\/s10557-021-07157-3"},{"doi-asserted-by":"publisher","key":"e_1_3_5_19_1","DOI":"10.1007\/978-3-319-61845-6_38"},{"doi-asserted-by":"publisher","key":"e_1_3_5_20_1","DOI":"10.1016\/S2213-8587(18)30315-2"},{"doi-asserted-by":"publisher","key":"e_1_3_5_21_1","DOI":"10.1161\/CIRCULATIONAHA.115.017926"},{"doi-asserted-by":"publisher","key":"e_1_3_5_22_1","DOI":"10.2337\/dc19-1459"},{"doi-asserted-by":"publisher","key":"e_1_3_5_23_1","DOI":"10.1136\/bmj.m4573"},{"doi-asserted-by":"crossref","unstructured":"Li S Vandvik PO Lytvyn L et al. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline. BMJ. 2021;373:p. n1091.","key":"e_1_3_5_24_1","DOI":"10.1136\/bmj.n1091"},{"doi-asserted-by":"publisher","key":"e_1_3_5_25_1","DOI":"10.2337\/dci19-0066"},{"doi-asserted-by":"publisher","key":"e_1_3_5_26_1","DOI":"10.2337\/dc16-0041"},{"doi-asserted-by":"publisher","key":"e_1_3_5_27_1","DOI":"10.1002\/jcph.1561"},{"doi-asserted-by":"publisher","key":"e_1_3_5_28_1","DOI":"10.1186\/s12933-021-01390-8"},{"doi-asserted-by":"publisher","key":"e_1_3_5_29_1","DOI":"10.7326\/M21-0893"},{"doi-asserted-by":"publisher","key":"e_1_3_5_30_1","DOI":"10.1111\/bcp.15178"},{"doi-asserted-by":"publisher","key":"e_1_3_5_31_1","DOI":"10.1016\/j.numecd.2018.02.014"},{"doi-asserted-by":"publisher","key":"e_1_3_5_32_1","DOI":"10.1186\/s12933-021-01243-4"},{"doi-asserted-by":"publisher","key":"e_1_3_5_33_1","DOI":"10.3389\/fphar.2021.731757"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2216453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T10:19:21Z","timestamp":1716805161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2216453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/14740338.2023.2216453"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2216453","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}